Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting DNA to cells with basic fibroblast growth factor (FGF2)

B A Sosnowski1, A M Gonzalez, L A Chandler

  • 1PRIZM Pharmaceuticals, San Diego, California 92121, USA.

The Journal of Biological Chemistry
|December 27, 1996
PubMed
Summary

Researchers developed a novel method for DNA delivery using basic fibroblast growth factor (FGF2) conjugated to polylysine, enhancing gene expression in target cells via FGF receptors. This ligand-mediated gene targeting shows potential for future therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physicochemical and functional characterization of the mucilage obtained from cladodes of two Opuntia species.

International journal of biological macromolecules·2024
Same author

Dualism, allosteric modulation, and biased signaling of opioid receptors: Future therapeutic potential.

Revista espanola de anestesiologia y reanimacion·2023
Same author

The relevance of false positive acid phosphatase reactions indicative of the presence of seminal fluid from oral and vaginal samples.

Science & justice : journal of the Forensic Science Society·2023
Same author

Homogeneous colleters in Myrteae (Myrtaceae).

Protoplasma·2023
Same author

Oromandibular-limb hypogenesis syndromes (OLHS): A challenge for airway management.

Revista espanola de anestesiologia y reanimacion·2021
Same author

Analysis of the care management protocol for COVID pregnant women and detection of improvement proposals applying clinical simulation methodology.

Revista espanola de anestesiologia y reanimacion·2020

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Ligand-mediated DNA targeting offers a potential route for non-viral gene delivery.
  • Fibroblast Growth Factor 2 (FGF2) is known to interact with cell surface receptors, suggesting its potential as a targeting ligand.

Purpose of the Study:

  • To validate ligand-mediated DNA targeting using FGF2 conjugated to polylysine.
  • To investigate the efficiency and specificity of FGF2-mediated DNA delivery into cells.

Main Methods:

  • Condensation of plasmid DNA encoding beta-galactosidase (beta-gal) with FGF2-polylysine conjugate.
  • Transfection of FGF2-target cells (COS-1, 3T3, BHK, endothelial cells) with the DNA complex.
  • Assessment of beta-gal expression and FGF receptor specificity using competition assays and endocytosis inhibitors (chloroquine, endosome-disruptive peptides).

Related Experiment Videos

Main Results:

  • Optimal FGF2-DNA binding conditions correlated with highest beta-gal expression.
  • Beta-gal activity showed time- and dose-dependent increases, dependent on FGF2.
  • FGF receptor specificity was confirmed by competition assays; cytochrome c and histone H1 did not yield similar effects.
  • Endocytosis pathway was crucial, with chloroquine and endosome-disruptive peptides significantly enhancing beta-gal expression.

Conclusions:

  • DNA can be effectively introduced into cells via the high-affinity FGF receptor complex.
  • While current efficiency requires improvement for sustained transgene expression, this method shows promise for targeted DNA delivery.
  • The potential application for delivering DNA encoding cytotoxic molecules is highlighted.